$1.14
-0.10[-8.06%]
At close: May 17
$1.14
0[0.00%]
After Hours: 6:26PM EDT
Biodexa Pharmaceuticals
(NASDAQ:BDRX)Biodexa Pharmaceuticals Stock (NASDAQ:BDRX), Quotes and News Summary
Biodexa Pharmaceuticals Stock (NASDAQ: BDRX) stock price, news, charts, stock research, profile.
| Open | $1.370 |
| Close | $1.190 |
| Volume / Avg. | 487.464K / 2.909M |
| Day Range | 1.160 - 1.370 |
| 52 Wk Range | 0.670 - 20.392 |
| Market Cap | $4.999M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 53 |
| Short Interest | 46.89% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biodexa Pharmaceuticals (BDRX) stock?
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ: BDRX) through any online brokerage.
Who are Biodexa Pharmaceuticals's (BDRX) competitors?
Other companies in Biodexa Pharmaceuticals’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX) and NexImmune (NASDAQ:NEXI).
What is the target price for Biodexa Pharmaceuticals (BDRX) stock?
The latest price target for Biodexa Pharmaceuticals (NASDAQ: BDRX) was reported by Ladenburg Thalmann on Thursday, February 8, 2024. The analyst firm set a price target for 8.00 expecting BDRX to rise to within 12 months (a possible 601.75% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Biodexa Pharmaceuticals (BDRX)?
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $1.14 last updated May 17, 2024 at 6:26 PM EDT.
Does Biodexa Pharmaceuticals (BDRX) pay a dividend?
There are no upcoming dividends for Biodexa Pharmaceuticals.
When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?
Biodexa Pharmaceuticals’s FY earnings are confirmed for Friday, May 31, 2024.
Is Biodexa Pharmaceuticals (BDRX) going to split?
There is no upcoming split for Biodexa Pharmaceuticals.
What sector and industry does Biodexa Pharmaceuticals (BDRX) operate in?
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.